Modulators of the ghrelin system as potential treatments for obesity and diabetes

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.11, 2008-11, pp. : 1253-1263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ghrelin as a Potential Anti-Obesity Target

Current Pharmaceutical Design, Vol. 9, Iss. 17, 2003-07 ,pp. : 1383-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Methods for synthesis and uses of inhibitors of Ghrelin O-acyltransferase inhibitors as potential therapeutic agents for obesity and diabetes

By Costantino Luca

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1603-1607

Informa Healthcare

Access to resources Recommend Favorite

Potential new treatments for type 2 diabetes

By Bailey C.J.

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics: potential role in the treatment of diabetes and obesity

By Vella Adrian Camilleri Michael

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1109-1119

Informa Healthcare

Access to resources Recommend Favorite

Adiponectin: potential in diabetes and obesity?

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite